[1]
Davison, MD, MHSc (bioethics), FRCP(C), S.N. and Mayo, PhD, SFO, P.R. 2018. Pain management in chronic kidney disease: The pharmacokinetics and pharmacodynamics of hydromorphone and hydromorphone-3-glucuronide in hemodialysis patients. Journal of Opioid Management. 4, 6 (Jan. 2018), 335–344. DOI:https://doi.org/10.5055/jom.2008.0037.